Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?

Gastric carcinoid in the absence of atrophic body gastritis and with low Ki67 index: a clinical challenge

(2014) Edith Lahner et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Important of case-reports/series, in rare diseases: Using neuroendocrine tumors as an example

(2014) Taichi Nakamura   World Journal of Clinical Cases

The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin

(2013) Hólmfridur Helgadóttir et al.   DIGESTIVE AND LIVER DISEASE

Long-term, open-label trial: safety and efficacy of continuous maintenance treatment with pantoprazole for up to 15 years in severe acid-peptic disease

(2012) G. Brunner et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gastric carcinoids after long-term use of a proton pump inhibitor

(2012) C. S. Jianu et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial

(2012) R. Fiocca et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms

(2012) Gianfranco Delle Fave et al.   NEUROENDOCRINOLOGY

Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia

(2011) E. Hassall et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adverse Effects of Long-Term Proton Pump Inhibitor Therapy

(2011) Edward Sheen et al.   DIGESTIVE DISEASES AND SCIENCES

Type I Gastric Carcinoids: A Prospective Study on Endoscopic Management and Recurrence Rate

(2011) Elettra Merola et al.   NEUROENDOCRINOLOGY

Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor

(2011) Constantin S Jianu et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Adverse effects of proton pump inhibitor drugs: clues and conclusions

(2010) Denis M McCarthy   CURRENT OPINION IN GASTROENTEROLOGY

Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters

(2010) Martin B Niederle et al.   ENDOCRINE-RELATED CANCER

Safety of the long-term use of proton pump inhibitors

(2010) Alan BR Thomson   WORLD JOURNAL OF GASTROENTEROLOGY

Evidence That Proton-Pump Inhibitor Therapy Induces the Symptoms it Is Used to Treat

(2009) Kenneth E.L. McColl et al.   GASTROENTEROLOGY